Market Tracker

12/19 11:01pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

16.85
Data as of Dec 19
 -0.14 / -0.82%
Today’s Change
2.65
Today|||52-Week Range
17.05
+401.49%
Year-to-Date

Today’s Trading

Previous close16.99
Today’s open16.94
Day’s range16.85 - 16.98
Volume13,891,937
Average volume (3 months)6,508,579
Market cap$3.3B
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+41.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+19.16%
Revenue growth (last year)+52.63%
P/E ratioNM
Price/Sales16.71
Price/Book11.94

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.13+0.41%
ICPTIntercept Pharmaceut...+6.49+4.32%
NPSPNPS Pharmaceuticals ...-0.57-1.56%
MYGNMyriad Genetics Inc+0.85+2.39%
Data as of 4:00pm ET, 12/19/2014

Financials

Last reporting dateDecember 10, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$115.0M
Annual profit (last year)-$50.4M
Net profit margin-43.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary, CAO &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts